Suppr超能文献

登革热疫苗:最新进展。

Dengue vaccines: state of the art.

机构信息

International Centre for Genetic Engineering & Biotechnology, Recombinant Gene Products Group, PO Box 10504, Aruna Asaf Ali Marg, New Delhi-110067, India.

出版信息

Expert Opin Ther Pat. 2010 Jun;20(6):819-35. doi: 10.1517/13543771003767476.

Abstract

IMPORTANCE OF THE FIELD

Dengue is a significant public health problem transcending geographical boundaries to place nearly 50% of the global population at risk. A vaccine to prevent dengue is an unmet need that should be addressed urgently.

AREAS COVERED IN THE REVIEW

A brief introduction to dengue and a detailed review of the classical and modern approaches being undertaken currently to develop dengue vaccines described in recent patent literature, highlighting the inherent hurdles and challenges.

WHAT THE READER WILL GAIN

An understanding of the approaches being deployed to develop multiple viral and non-viral vaccine candidates and an appreciation of the complexity of developing dengue vaccines.

TAKE HOME MESSAGE

Live viral vaccines, which have advanced to clinical trials, have revealed new challenges, emphasizing the need to pursue non-viral alternatives simultaneously.

摘要

重要性领域

登革热是一个重大的公共卫生问题,跨越地理界限,使近 50%的全球人口面临风险。预防登革热的疫苗是一个未满足的需求,应紧急解决。

综述涵盖的领域

简要介绍登革热,并详细回顾目前为开发登革热疫苗而采用的经典和现代方法,这些方法在最近的专利文献中有描述,强调了内在的障碍和挑战。

读者将获得的收益

了解为开发多种病毒和非病毒疫苗候选物而部署的方法,并认识到开发登革热疫苗的复杂性。

重要信息

已进入临床试验的活病毒疫苗揭示了新的挑战,强调需要同时寻求非病毒替代方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验